WEST LAFAYETTE, Ind., Nov. 3, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that the company will host a conference call on Thursday, November 10, 2011, at 4:30 PM Eastern Standard Time to discuss its third quarter 2011 financial results and provide an operational update.
